BRIEF-Takeda gets European conditional marketing authorization for Adcetris

LONDON Wed Oct 31, 2012 5:03am EDT

Related Topics

LONDON Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd : * Millennium and Takeda announce European conditional marketing authorization

for adcetris (brentuximab vedotin) * Millenium - Takeda intends to launch adcetris across Europe, with the first

launches planned in the coming weeks

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.